Antigen-specific activation of gut immune cells drives autoimmune neuroinflammation
Microbiome-based therapies are promising new treatment avenues. While global alterations in microbiota composition have been shown in multiple sclerosis, whether and how gut microbiota influence autoimmune responses in an antigen-specific manner is unclear. Here, we genetically engineered gut bacter...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
24 Dec 2025
|
| In: |
Gut microbes
Year: 2025, Volume: 18, Issue: 1, Pages: 1-20 |
| ISSN: | 1949-0984 |
| DOI: | 10.1080/19490976.2025.2601430 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1080/19490976.2025.2601430 |
| Author Notes: | Lena K. Siewert, Kristina Berve, Elisabeth Pössnecker, Julia Dyckow, Amel Zulji, Ryan Baumann, Aida Munoz-Blazquez, Gurumoorthy Krishnamoorthy, David Schreiner, Sharon Sagan, Charlotte Nelson, Joseph J. Sabatino Jr, Kazuki Nagashima, Médéric Diard, Andrew J. Macpherson, Stephanie C. Ganal-Vonarburg, Michael A. Fischbach, Scott S. Zamvil, Lucas Schirmer, Sergio E. Baranzini and Anne-Katrin Pröbstel |
| Summary: | Microbiome-based therapies are promising new treatment avenues. While global alterations in microbiota composition have been shown in multiple sclerosis, whether and how gut microbiota influence autoimmune responses in an antigen-specific manner is unclear. Here, we genetically engineered gut bacteria to express a brain antigen and dissect their pathogenic potential in a murine model of autoimmune neuroinflammation. Colonization with bacteria expressing myelin - but not ovalbumin-peptide exacerbates an encephalitogenic immune response in the gut by activating antigen-specific T cells as well as B cells leading to accelerated neuroinflammatory disease. These results demonstrate how antigen-specific microbial modulation can influence autoimmunity, providing insight for development of therapeutic strategies targeting specific bacterial taxa for treatment of MS and other autoimmune diseases. |
|---|---|
| Item Description: | Gesehen am 12.03.2026 |
| Physical Description: | Online Resource |
| ISSN: | 1949-0984 |
| DOI: | 10.1080/19490976.2025.2601430 |